Myron Z. Holubiak's Insider Trades & SAST Disclosures
Myron Z. Holubiak's most recent trade in Citius Oncology Inc. was a trade of 300,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Dec. 12, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Myron Z. Holubiak.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Citius Oncology Inc. | Myron Z. Holubiak | Director, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2024 | 300,000 | 300,000 | - | - | Stock Option (Right to Buy) | |
| Citius Oncology Inc. | Myron Z. Holubiak | Director, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Dec 2024 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Citius Pharmaceuticals Inc | Myron Z. Holubiak | Director, Vice Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2024 | 350,000 | 350,000 | - | - | Stock Option (Right to Purchase Common Stock) | |
| Citius Pharmaceuticals Inc | Myron Z. Holubiak | Director, Vice Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Nov 2024 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| Citius Pharmaceuticals Inc | Myron Z. Holubiak | Director, Vice Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2024 | 784,314 | 784,314 | - | - | Warrant to Purchase Common Stock | |
| Citius Pharmaceuticals Inc | Myron Z. Holubiak | Director, Vice Chairman | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2024 | 784,314 | 0 | - | - | Warrant to Purchase Common Stock | |
| Citius Pharmaceuticals Inc | Myron Z. Holubiak | Director, Vice Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Aug 2024 | 558,597 | 558,597 | - | - | Warrant to Purchase Common Stock | |
| Citius Pharmaceuticals Inc | Myron Z. Holubiak | Director, Vice Chairman | Sale or transfer of securities back to the company at price $ 0.00 per share. | 14 Aug 2024 | 558,597 | 0 | - | - | Warrant to Purchase Common Stock | |
| Citius Oncology Inc. | Myron Z. Holubiak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 1,500,000 | 1,500,000 | - | - | Stock Option (Right to Buy) | |
| Citius Oncology Inc. | Myron Z. Holubiak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) | |
| Citius Pharmaceuticals Inc | Myron Z. Holubiak | Director, Vice Chairman | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 Apr 2024 | 129,450 | 0 | - | - | Warrant to Purchase Common Stock | |
| Citius Pharmaceuticals Inc | Myron Z. Holubiak | Director, Vice Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2024 | 129,450 | 129,450 | - | - | Warrant to Purchase Common Stock | |
| Citius Pharmaceuticals Inc | Myron Z. Holubiak | Director, Vice Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2022 | 400,000 | 400,000 | - | - | Options to Purchase Common Stock | |
| Citius Pharmaceuticals Inc | Myron Z. Holubiak | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Oct 2021 | 650,000 | 650,000 | - | - | Options to Purchase Common Stock | |
| Citius Pharmaceuticals Inc | Myron Z. Holubiak | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Oct 2021 | 15,000 | 15,000 | - | - | Options to Purchase Common Stock | |
| Citius Pharmaceuticals Inc | Myron Z. Holubiak | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2021 | 300,000 | 300,000 | - | - | Options to Purchase Common Stock | |
| Citius Pharmaceuticals Inc | Myron Z. Holubiak | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2021 | 10,000 | 10,000 | - | - | Options to Purchase Common Stock | |
| Assembly Biosciences Inc | Myron Z. Holubiak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 15,000 | 15,000 | - | - | Stock Option (right to buy) | |
| Citius Pharmaceuticals Inc | Myron Z. Holubiak | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Oct 2020 | 200,000 | 200,000 | - | - | Options to Purchase Common Stock | |
| Assembly Biosciences Inc | Myron Z. Holubiak | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2020 | 10,000 | 10,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges